Silgan Holdings Inc. SLGN
35.91
0.46
1.30%
as of 25 Sep
- Market cap
- $3.8B
- P/E
- 14.1×
Follow SLGN
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
18.19 | 14.59 | 14.95 | 14.58 |
+8 more quarters Free account |
P/S ratio |
0.73 | 0.62 | 0.66 | 0.71 | |
P/FCF ratio |
14.31 | 13.34 | 10.17 | 70.28 | |
P/Operating CF |
(25.25) | (5.12) | 3.32 | 13.45 | |
P/B ratio |
2.06 | 1.77 | 1.89 | 2.02 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
1.41 | 1.27 | 1.17 | 1.42 | |
EV/EBITDA |
10.25 | 9.00 | 8.20 | 10.03 | |
EV/Operating CF |
14.65 | 13.56 | 10.37 | 24.59 | |
EV/FCF |
27.39 | 27.10 | 17.90 | 140.13 | |
Quick Ratio |
0.70 | 0.68 | 0.68 | 0.77 | |
Current Ratio |
1.27 | 1.26 | 1.22 | 1.27 | |
Net Debt/EBITDA |
18.98 | 19.82 | 17.78 | 16.12 | |
Debt/Assets |
50.35% | 49.99% | 46.26% | 52.09% | |
Debt/Equity |
2.03 | 2.01 | 1.91 | 2.18 | |
Asset Turnover |
0.70 | 0.73 | 0.72 | 0.75 | |
Operating CF/Net income |
(2.56) | (12.68) | 71.07 | 3.01 | |
Capex/Depreciation |
(0.75) | (0.95) | (0.86) | (0.95) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
7.72% | 8.40% | 8.14% | 6.08% | |
Intangible Assets out of Total Assets |
0.35 | 0.36 | 0.36 | 0.36 | |
Share Based Compensation of Revenue |
0.39% | 0.37% | 0.35% | 0.26% | |
Graham Net Nets |
(0.80) | (0.98) | (0.96) | (0.90) | |
Graham Number |
35.93 | 36.27 | 36.01 | 37.61 | |
Earnings Yield |
5.50% | 6.86% | 6.69% | 6.86% | |
Free Cash Flow Yield |
6.99% | 7.49% | 9.83% | 1.42% | |
Revenue per Share |
15.54 | 14.79 | 13.78 | 18.84 | |
Operating CF per Share |
(1.84) | (7.57) | 12.14 | 3.20 | |
Capex per Share |
(0.61) | (0.78) | (0.67) | (0.75) | |
Free Cash Flow per Share |
(2.44) | (8.35) | 11.47 | 2.45 | |
Cash per Share |
3.32 | 4.12 | 10.14 | 3.65 | |
Shareholders Equity per Share |
22.50 | 21.98 | 21.35 | 21.31 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
22.50 | 21.98 | 21.35 | 21.31 | |
Free Cash Flow |
(258.52) | (882.02) | 1,222.51 | 260.79 | |
Working Capital |
704.02 | 608.99 | 540.05 | 661.33 | |
Capital Expenditures |
(64.24) | (82.44) | (71.30) | (80.10) | |
Net Current Asset Value |
(3,927.44) | (4,034.92) | (4,130.86) | (4,113.43) | |
EV/EBIT |
16.26 | 14.01 | 12.66 | 15.47 | |
Capex to Sales |
0.04 | 0.05 | 0.05 | 0.04 | |
Net Profit Margin |
4.61% | 4.04% | 1.24% | 5.64% | |
Price to Operating Income |
8.50 | 6.90 | 7.19 | 7.76 | |
| Other line items | |||||
Average Receivables |
1,348.37 | 1,085.74 | 591.84 | 1,356.57 | |
Average Payables |
824.62 | 776.93 | 1,181.75 | 765.02 | |
Average Inventory |
1,245.30 | 1,092.02 | 1,004.10 | 901.40 | |
Average Assets |
9,505.54 | 9,045.13 | 8,990.88 | 8,622.78 | |
Average Common Equity |
2,300.80 | 2,201.97 | 2,131.94 | 2,163.21 |
Columns are period end dates